Multimodal Machine Learning-Based Clinical and Genomic Prognostic Factors for Progression-Free Survival in Metastatic Breast Cancer Using Phase III MONALEESA Trials
Purpose: Cyclin-dependent kinase 4/6 inhibitors in combination with endocrine therapy have become widely adopted as a first-line treatment approach for hor